Patents by Inventor Julia Tsai

Julia Tsai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ganaxolone for use in treatment of status epilepticus
    Patent number: 12246026
    Abstract: This invention relates to methods for treating status epilepticus by administering to the subject in need thereof an intravenous bolus of ganaxolone and a continuous intravenous infusion of a neurosteroid. The method provides SE suppression and continued suppression of SE.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: March 11, 2025
    Assignee: Marinus Pharmaceuticals, Inc.
    Inventors: David Czekai, Maciej Gasior, Lorianne Masuoka, Julia Tsai, Joseph Hulihan, Alex Aimetti
  • GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS
    Publication number: 20230405021
    Abstract: This invention relates to methods for treating status epilepticus by administering to the subject in need thereof an intravenous bolus of ganaxolone and a continuous intravenous infusion of a neurosteroid. The method provides SE suppression and continued suppression of SE.
    Type: Application
    Filed: August 28, 2023
    Publication date: December 21, 2023
    Inventors: David CZEKAI, Maciej GASIOR, Lorianne MASUOKA, Julia TSAI, Joseph HULIHAN, Alex AIMETTI
  • Ganaxolone for use in treatment of status epilepticus
    Patent number: 11679117
    Abstract: This invention relates to methods for treating status epilepticus by administering to the subject in need thereof an intravenous bolus of ganaxolone and a continuous intravenous infusion of a neurosteroid. The method provides SE suppression and continued suppression of SE.
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: June 20, 2023
    Assignee: Marinus Pharmaceuticals, Inc.
    Inventors: David Czekai, Maciej Gasior, Lorianne Masuoka, Julia Tsai, Joseph Hulihan, Alex Aimetti
  • GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS
    Publication number: 20220265680
    Abstract: This invention relates to methods for treating status epilepticus by administering to the subject in need thereof an intravenous bolus of ganaxolone and a continuous intravenous infusion of a neurosteroid. The method provides SE suppression and continued suppression of SE.
    Type: Application
    Filed: April 26, 2022
    Publication date: August 25, 2022
    Inventors: David CZEKAI, Maciej GASIOR, Lorianne MASUOKA, Julia TSAI, Joseph HULIHAN, Alex AIMETTI
  • GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS
    Publication number: 20220202831
    Abstract: This invention relates to methods for treating status epilepticus by administering to the subject in need thereof an intravenous bolus of ganaxolone and a continuous intravenous infusion of a neurosteroid. The method provides SE suppression and continued suppression of SE.
    Type: Application
    Filed: August 4, 2021
    Publication date: June 30, 2022
    Inventors: David CZEKAI, Maciej GASIOR, Lorianne MASUOKA, Julia TSAI, Joseph HULIHAN, Alex AIMETTI
  • Ganaxolone for use in treatment of status epilepticus
    Patent number: 11110100
    Abstract: This invention relates to methods for treating status epilepticus by administering to the subject in need thereof an intravenous bolus of ganaxolone and a continuous intravenous infusion of a neurosteroid. The method provides SE suppression and continued suppression of SE.
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: September 7, 2021
    Assignee: Marinus Pharmaceuticals, Inc.
    Inventors: David Czekai, Maciej Gasior, Lorianne Masuoka, Julia Tsai, Joseph Hulihan, Alex Aimetti
  • GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS
    Publication number: 20210186987
    Abstract: This invention relates to methods for treating status epilepticus by administering to the subject in need thereof an intravenous bolus of ganaxolone and a continuous intravenous infusion of a neurosteroid. The method provides SE suppression and continued suppression of SE.
    Type: Application
    Filed: February 26, 2021
    Publication date: June 24, 2021
    Inventors: David CZEKAI, Maciej GASIOR, Lorianne MASUOKA, Julia TSAI, Joseph HULIHAN, Alex AIMETTI
  • ELECTRONIC EDGE COMPUTING DEVICE
    Publication number: 20200226893
    Abstract: According to one embodiment, an electronic edge computing device is without a display and without a hardware input keyboard. The electronic edge computing device includes a light source and a controller. The light source emits light of at least two colors. A light emission mode of the light source comprises an on mode, a blink mode, and an off mode. The controller controls a color of the light emitted from the light source and the light emission mode of the light source based at least in part on a state of the electronic edge computing device.
    Type: Application
    Filed: March 30, 2020
    Publication date: July 16, 2020
    Inventors: Masanori Nakano, Sy Pan, Julia Tsai
  • ELECTRONIC EDGE COMPUTING DEVICE
    Publication number: 20190206199
    Abstract: According to one embodiment, an electronic edge computing device is without a display and without a hardware input keyboard. The electronic edge computing device includes a light source and a controller. The light source emits light of at least two colors. A light emission mode of the light source comprises an on mode, a blink mode, and an off mode. The controller controls a color of the light emitted from the light source and the light emission mode of the light source based at least in part on a state of the electronic edge computing device.
    Type: Application
    Filed: June 27, 2018
    Publication date: July 4, 2019
    Inventors: Masanori Nakano, Sy Pan, Julia Tsai